Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KYNTRA BIO, INC.FGEN · Entity 7431 | Chief Medical Officer | December 16, 2020 | December 18, 2020 |
| STAAR SURGICAL COSTAA · Entity 4851 | Director | June 15, 2023 | June 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KYNTRA BIO, INC.
Report date December 16, 2020 · Filed December 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 192,292 |
Reported balance
After 2020-12-16 transaction · row 1
1 source rowRow 1 · 2020-12-16 · Sale · Disposed 3,350 · Balance 192,292 F1: Shares sold pursuant to a 10b5-1 plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold pursuant to a 10b5-1 plan.
STAAR SURGICAL CO
Report date June 15, 2023 · Filed June 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,786 |
Reported balance
After 2023-06-15 transaction · row 1
1 source rowRow 1 · 2023-06-15 · Exercise / conversion · Acquired 1,709 · Balance 2,786 F1: The restrictions on the 1709 restricted shares of common stock lapse on the earlier of June 15, 2023 or the Corporation's 2024 Annual Meeting, subject to Dr. Yu's continued service through that date. |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $52.67 · Expires 2034-06-14 | Direct | 3,127 |
Reported balance
After 2023-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-15 · Exercise / conversion · Acquired 3,127 · Balance 3,127 F2: The options vest on the earlier of June 15, 2024 or the Corporation's 2024 Annual Shareholders Meeting, subject to her continued service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restrictions on the 1709 restricted shares of common stock lapse on the earlier of June 15, 2023 or the Corporation's 2024 Annual Meeting, subject to Dr. Yu's continued service through that date.
F2: The options vest on the earlier of June 15, 2024 or the Corporation's 2024 Annual Shareholders Meeting, subject to her continued service through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2017 Filed Mar 9, 2017 01:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 41,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-019467 · doc4.xml · nonDerivative · entry 2 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,897 F2 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2018, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 06, 2017 Filed Mar 9, 2017 01:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 4,727 | $25.35 | $119,829.45 |
DisclosureSEC source: 0001209191-17-019467 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,721 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 23:12 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,000 | $23.56 | $117,800.00 |
DisclosureSEC source: 0001209191-17-003557 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,448 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $23.10 to $23.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 23:52 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,344 | $20.65 | $48,403.60 |
DisclosureSEC source: 0001209191-16-155724 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,448 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 01, 2016 Filed Dec 3, 2016 01:46 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,410 | $20.55 | $28,975.50 |
DisclosureSEC source: 0001209191-16-153186 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,792 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 01:03 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,700 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-16-148950 · doc4.xml · derivative · entry 4 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 2,700 shares Expires 2022-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 01:03 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-16-148950 · doc4.xml · derivative · entry 3 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2021-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 01:03 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 2,700 | $5.95 | $16,065.00 |
DisclosureSEC source: 0001209191-16-148950 · doc4.xml · nonDerivative · entry 2 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 01:03 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 2,000 | $3.50 | $7,000.00 |
DisclosureSEC source: 0001209191-16-148950 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2016 Filed Sep 15, 2016 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,345 | $18.66 | $43,757.70 |
DisclosureSEC source: 0001209191-16-141653 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,502 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.